Outcome of Patients With Central Nervous System Multiple Myeloma (CNS-MM) Treated With CNS-Directed Radiation Therapy.
Saved in:
| Title: | Outcome of Patients With Central Nervous System Multiple Myeloma (CNS-MM) Treated With CNS-Directed Radiation Therapy. |
|---|---|
| Authors: | Manzar GS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX; Department of Musculoskeletal Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX., Dudzinski SO; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Yoder AK; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Seo A; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Nasr LF; Department of Lymphoma-Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX., Rafei H; Department of Stem Cell Transplantation, The University of Texas MD Anderson Cancer Center, Houston, TX., Becnel MR; Department of Lymphoma-Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX., Patel KK; Department of Lymphoma-Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX., Lee HC; Department of Lymphoma-Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX., Kaufman GP; Department of Lymphoma-Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX., Gaballa MM; Department of Lymphoma-Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX., Ye JC; Department of Lymphoma-Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX., Saini N; Department of Lymphoma-Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX., Thomas SK; Department of Lymphoma-Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX., Amini B; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX., Orlowski RZ; Department of Lymphoma-Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX., Dabaja BS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Pinnix CC; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Gunther JR; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Wu SY; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Fang PQ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address: pfang@mdanderson.org. |
| Source: | Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2025 Apr; Vol. 25 (4), pp. 271-284. Date of Electronic Publication: 2024 Nov 22. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 101525386 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2152-2669 (Electronic) Linking ISSN: 21522669 NLM ISO Abbreviation: Clin Lymphoma Myeloma Leuk Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
